Suppr超能文献

首例在生物活性可降解髓内植入物上进行伊里扎洛夫股骨延长术的临床病例。

First Clinical Case of Ilizarov Femur Lengthening over a Bioactive and Degradable Intramedullary Implant.

作者信息

Popkov Arnold, Tverdokhlebov Sergei, Muradisinov Sergei, Popkov Dmitry

机构信息

Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics, Kurgan, Russia.

Tomsk Polytechnic University, Tomsk, Russia.

出版信息

Case Rep Orthop. 2023 Dec 7;2023:7547590. doi: 10.1155/2023/7547590. eCollection 2023.

Abstract

INTRODUCTION

The Ilizarov distraction osteogenesis is a recognized method of limb lengthening in orthopaedic practice. Its most challenging problems are long duration of external fixation and related pin-tract infection and joint contractures. The solution might be the use of a bioactive degradable intramedullary implant stimulating bone healing. . We present a case of a 14-year-old boy with 6 cm posttraumatic shortening of the femur and associated varus deformity of 20 degrees. He was treated with the Ilizarov technique of femur lengthening over an intramedullary degradable polycaprolactone (PCL) implant with hydroxyapatite (HA) filling. We faced no complications within the lengthening process. Shortening and deformity of the femur were corrected in 90 days. The index of external fixation was 15 days/cm. External fixation time was reduced almost twice comparing to the conventional method. Degradable intramedullary nails ensured the advantage of avoidance of the removal procedure. Radiography and CT confirmed faster new bone healing and remodeling.

CONCLUSION

The combined lengthening technique over a PCL/HA implant might be used to shorten external fixation time and to stimulate bone healing especially in patients with compromised bone. Using a bioabsorbable material presents the benefit of eliminating the need for a second surgery to remove the nail, thereby reducing soft tissue damage.

摘要

引言

伊里扎洛夫牵张成骨术是骨科实践中公认的肢体延长方法。其最具挑战性的问题是外固定时间长以及相关的针道感染和关节挛缩。解决方案可能是使用一种刺激骨愈合的生物活性可降解髓内植入物。我们报告一例14岁男孩,股骨创伤后缩短6厘米,并伴有20度内翻畸形。他接受了伊里扎洛夫股骨延长技术治疗,在髓内可降解聚己内酯(PCL)植入物中填充羟基磷灰石(HA)。在延长过程中我们未遇到并发症。股骨缩短和畸形在90天内得到矫正。外固定指数为15天/厘米。与传统方法相比,外固定时间几乎减少了一半。可降解髓内钉确保了避免取出手术的优势。X线和CT证实新骨愈合和重塑更快。

结论

PCL/HA植入物联合延长技术可用于缩短外固定时间并刺激骨愈合,尤其是在骨质量受损的患者中。使用生物可吸收材料具有无需二次手术取出钉子的优点,从而减少软组织损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acdc/10721347/8c184f9bab73/CRIOR2023-7547590.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验